Citations (300)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Christodouli Lagogianni, Shirley Thomas & Nadina Lincoln. (2018) Examining the relationship between fatigue and cognition after stroke: A systematic review. Neuropsychological Rehabilitation 28:1, pages 57-116.
Read now
Read now
Grandhi Venkata Ramalingayya, Sri Pragnya Cheruku, Pawan G Nayak, Anoop Kishore, Rekha Shenoy, Chamallamudi Mallikarjuna Rao & Nandakumar Krishnadas. (2017) Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats. Drug Design, Development and Therapy 11, pages 1011-1026.
Read now
Read now
Theresa A Koleck & Yvette P Conley. (2016) Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level. Breast Cancer: Targets and Therapy 8, pages 29-37.
Read now
Read now
Marie Lange, Natacha Heutte, Nastassja Morel, Francis Eustache, Florence Joly & Bénédicte Giffard. (2016) Cognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog), normative data from a healthy population. Neuropsychological Rehabilitation 26:3, pages 392-409.
Read now
Read now
Michelle C. Janelsins, Shelli R. Kesler, Tim A. Ahles & Gary R. Morrow. (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry 26:1, pages 102-113.
Read now
Read now
Aude Caplette-Gingras, Josée Savard, Marie-Hélène Savard & Hans Ivers. (2013) Is Insomnia Associated With Cognitive Impairments in Breast Cancer Patients?. Behavioral Sleep Medicine 11:4, pages 239-257.
Read now
Read now
Barbara Collins, Joyce Mackenzie & Catherine Kyeremanteng. (2013) Study of the cognitive effects of chemotherapy: Considerations in selection of a control group. Journal of Clinical and Experimental Neuropsychology 35:4, pages 435-444.
Read now
Read now
Carole Scherling, Barbara Collins, Joyce MacKenzie, Catherine Bielajew & Andra Smith. (2012) Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study. Journal of Clinical and Experimental Neuropsychology 34:5, pages 543-560.
Read now
Read now
Caroline H. Walker, Barbara A. Drew, James W. Antoon, Alan V. Kalueff & Barbara S. Beckman. (2012) Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives. Cancer Investigation 30:2, pages 135-148.
Read now
Read now
Philip
G. Gasquoine. (2011) Cognitive impairment in common, noncentral nervous system medical conditions of adults and the elderly. Journal of Clinical and Experimental Neuropsychology 33:4, pages 486-496.
Read now
Read now
Lisa Lejbak, Mirna Vrbancic & Margaret Crossley. (2010) Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer. Journal of Clinical and Experimental Neuropsychology 32:8, pages 836-846.
Read now
Read now
Katharine Jean Vearncombe & Nancy A. Pachana. (2009) Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer. Australian Psychologist 44:4, pages 235-247.
Read now
Read now
Diane Von Ah, Kyle W. Harvison, Patrick O. Monahan, Lyndsi R. Moser, Qianqian Zhao, Janet S. Carpenter, George W. Sledge Jr, Victoria L. Champion & Frederick W. Unverzagt. (2009) Cognitive Function in Breast Cancer Survivors Compared to Healthy Age- and Education-Matched Women. The Clinical Neuropsychologist 23:4, pages 661-674.
Read now
Read now
L. A. Ouimet, A. Stewart, B. Collins, D. Schindler & C. Bielajew. (2009) Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology 31:1, pages 73-89.
Read now
Read now
Kelly A. Biegler, M. Alejandro Chaoul & Lorenzo Cohen. (2009) Cancer, cognitive impairment, and meditation. Acta Oncologica 48:1, pages 18-26.
Read now
Read now
Christina M. Schilder, Petronella C. Eggens, Caroline Seynaeve, Sabine C. Linn, Willem Boogerd, Chad M. Gundy, Louk V. Beex, Frits S. Van Dam & Sanne B. Schagen. (2009) Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncologica 48:1, pages 76-85.
Read now
Read now
Sanne B. Schagen, Willem Boogerd, Martin J. Muller, Wim Ten Bokkel Huinink, Luc Moonen, Wim Meinhardt & Frits S.A.M. Van Dam. (2008) Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncologica 47:1, pages 63-70.
Read now
Read now
Irene Perez Vetto & JohnT. Vetto. (2007) Cognitive Dysfunction in Cancer Patients: An Educational Needs Area Improved by a Single Intervention. Journal of Cancer Education 22:3, pages 197-201.
Read now
Read now
PeterC. Badgio & BlaiseL. Worden. (2007) Cognitive Functioning and Aging in Women. Journal of Women & Aging 19:1-2, pages 13-30.
Read now
Read now
Arti Hurria, George Somlo & Tim Ahles. (2007) Renaming “Chemobrain”. Cancer Investigation 25:6, pages 373-377.
Read now
Read now
Angela Stewart, Catherine Bielajew, Barbara Collins, Matthew Parkinson & Eva Tomiak. (2006) A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer. The Clinical Neuropsychologist 20:1, pages 76-89.
Read now
Read now
Articles from other publishers (279)
Stephanie C. Goodhew & Mark Edwards. (2024) The Cognitive Failures Questionnaire 2.0. Personality and Individual Differences 218, pages 112472.
Crossref
Crossref
Jose L. Tapia, María Teresa Taberner-Bonastre, David Collado-Martínez, Athanasios Pouptsis, Martín Núñez-Abad & Jon Andoni Duñabeitia. (2023) Effectiveness of a Computerized Home-Based Cognitive Stimulation Program for Treating Cancer-Related Cognitive Impairment. International Journal of Environmental Research and Public Health 20:6, pages 4953.
Crossref
Crossref
Kazuya Saita, Satoru Amano, Fumiko Kaneko & Hitoshi Okamura. (2023) A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors. Frontiers in Human Neuroscience 17.
Crossref
Crossref
Bethany Chapman, Nazanin Derakshan & Elizabeth A. Grunfeld. (2022) Experiences of cognitive training on primary breast cancer survivor's cognitive impairments at work: A longitudinal qualitative study. British Journal of Health Psychology 28:1, pages 252-270.
Crossref
Crossref
Robert J. Ferguson, Jessica Manculich, Hsuan Chang, Nikita J. Sareen, Beth E. Snitz, Lauren Terhorst, Dana H. Bovbjerg & Anette U. Duensing. (2022) Self‐reported cognitive impairments and quality of life in patients with gastrointestinal stromal tumor: Results of a multinational survey. Cancer 128:22, pages 4017-4026.
Crossref
Crossref
Sara Invitto, Mariangela Leucci, Giuseppe Accogli, Andrea Schito, Claudia Nestola, Vincenzo Ciccarese, Ross Rinaldi, Paolo Boscolo Rizzo, Giacomo Spinato & Silvana Leo. (2022) Chemobrain, Olfactory and Lifestyle Assessment in Onco-Geriatrics: Sex-Mediated Differences between Chemotherapy and Immunotherapy. Brain Sciences 12:10, pages 1390.
Crossref
Crossref
Nira Cedres, Andrea Aejmelaeus-Lindström, Ingrid Ekström, Steven Nordin, Xin Li, Jonas Persson & Jonas K Olofsson. (2022) Subjective Impairments in Olfaction and Cognition Predict Dissociated Behavioral Outcomes. The Journals of Gerontology: Series B.
Crossref
Crossref
Brenna C. McDonald, Kathleen Van Dyk, Rachael L. Deardorff, Jessica N. Bailey, Wanting Zhai, Judith E. Carroll, James C. Root, Tim A. Ahles, Jeanne S. Mandelblatt & Andrew J. Saykin. (2022) Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy. Breast Cancer Research and Treatment 194:1, pages 113-126.
Crossref
Crossref
Bethany Chapman, Nazanin Derakshan & Elizabeth A. Grunfeld. (2021) Exploring primary breast cancer survivors' self‐management of sustained cancer‐related cognitive impairment in the workplace. Psycho-Oncology 31:4, pages 606-613.
Crossref
Crossref
Alexandra L. Whittaker, Rebecca P. George & Lucy O’Malley. (2022) Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis. Scientific Reports 12:1.
Crossref
Crossref
Cecilie R. Buskbjerg, Robert Zachariae, Mads Agerbæk, Claus H. Gravholt, Lene Haldbo-Classen, S. M. Hadi Hosseini & Ali Amidi. (2021) Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients. Brain Imaging and Behavior 16:1, pages 199-210.
Crossref
Crossref
Ogün Bülbül, Sibel Göksel & Demet Nak. (2022) Changes in glucose metabolism of the brain after immunochemotherapy in patients with diffuse large B-Cell lymphoma on fluorodeoxyglucose positron emission tomography/computed tomography. Journal of Radiation and Cancer Research 0:0, pages 0.
Crossref
Crossref
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, Maria de Lourdes Bastos, Susana Isabel Sá, João Paulo Capela, Félix Carvalho & Vera Marisa Costa. (2021) Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events. Archives of Toxicology 96:1, pages 11-78.
Crossref
Crossref
Belle H. de Rooij, Simone Oerlemans, Katrijn van Deun, Floortje Mols, Kelly M. de Ligt, Olga Husson, Nicole P. M. Ezendam, Meeke Hoedjes, Lonneke V. van de Poll‐Franse & Dounya Schoormans. (2021) Symptom clusters in 1330 survivors of 7 cancer types from the PROFILES registry: A network analysis. Cancer 127:24, pages 4665-4674.
Crossref
Crossref
Zuzana Országhová, Michal Mego & Michal Chovanec. (2021) Long-Term Cognitive Dysfunction in Cancer Survivors. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martinez-Canabal & Gordon Winocur. (2021) Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions. International Journal of Molecular Sciences 22:23, pages 12697.
Crossref
Crossref
Jessica Swainston, Courtney Louis, Jason Moser & Nazanin Derakshan. (2021) Neurocognitive efficiency in breast cancer survivorship: A performance monitoring ERP study. International Journal of Psychophysiology 168, pages 9-20.
Crossref
Crossref
Fatima Jebahi, Saryu Sharma, Jamie E. Bloss & Heather H. Wright. (2021) Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review. Psycho-Oncology 30:8, pages 1262-1277.
Crossref
Crossref
Austin Wesevich, Karen S. Johnson & Ivy Altomare. 2021. Common Issues in Breast Cancer Survivors. Common Issues in Breast Cancer Survivors
139
152
.
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers & George William Rebeck. (2020) Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE. Cancers 12:12, pages 3842.
Crossref
Crossref
Jessica Fogel, Leah H. Rubin, Ece Kilic, David R. Walega & Pauline M. Maki. (2020) Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors. Menopause 27:11, pages 1209-1219.
Crossref
Crossref
Stefania Turrina, Filippo Gibelli & Domenico De Leo. (2020) Chemotherapy-induced cognitive impairment from the forensic medicine perspective: A review of the updated literature. Journal of Forensic and Legal Medicine 76, pages 102070.
Crossref
Crossref
Andrew M. Novick, Anthony T. Scott, C. Neill Epperson & Christopher D. Schneck. (2020) Neuropsychiatric effects of tamoxifen: Challenges and opportunities. Frontiers in Neuroendocrinology 59, pages 100869.
Crossref
Crossref
Priscilla Gates, Karla Gough, Haryana Dhillon, Carlene Wilson, Eliza Hawkes, Vincent Dore, Yuliya Perchyonok, Christopher C Rowe, Adam K Walker, Janette L Vardy, Michiel de Ruiter & Meinir Krishnasamy. (2020) Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study. BMJ Open 10:9, pages e038312.
Crossref
Crossref
Helena Sousa, Susana Almeida, João Bessa & M. Graça Pereira. (2020) The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies. Neuropsychology Review 30:3, pages 287-309.
Crossref
Crossref
Sarah Eide & Zhong-Ping Feng. (2020) Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis. European Journal of Pharmacology 881, pages 173078.
Crossref
Crossref
Sheila Shanmugan, Mary D. Sammel, James Loughead, Kosha Ruparel, Ruben C. Gur, Thomas E. Brown, Jessica Faust, Susan Domchek & C. Neill Epperson. (2020) Executive function after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: does current mood and early life adversity matter?. Menopause 27:7, pages 746-755.
Crossref
Crossref
Sena Yamamoto, Eiko Masutani & Harue Arao. (2020) Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy. Breast Cancer 27:4, pages 670-682.
Crossref
Crossref
Patricia A. Ganz & Kathleen Van Dyk. (2020) Cognitive Impairment in Patients With Breast Cancer: Understanding the Impact of Chemotherapy and Endocrine Therapy. Journal of Clinical Oncology 38:17, pages 1871-1874.
Crossref
Crossref
Lynne I. Wagner, Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina Yanez, Amye J. Tevaarwerk, Ruth C. Carlos, Kathy S. Albain, John A. OlsonJrJr, Matthew P. Goetz, Kathleen I. Pritchard, Daniel F. Hayes, Charles E. Geyer, E. Claire Dees, Worta J. McCaskill-Stevens, Lori M. Minasian, George W. SledgeJrJr & David Cella. (2020) Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx. Journal of Clinical Oncology 38:17, pages 1875-1886.
Crossref
Crossref
Annelise A. Madison, Alex Woody, Brittney Bailey, Maryam B. Lustberg, Bhuvaneswari Ramaswamy, Robert Wesolowski, Nicole Williams, Raquel Reinbolt, Jeffrey B. VanDeusen, Sagar Sardesai, William B. Malarkey & Janice K. Kiecolt-Glaser. (2020) Cognitive problems of breast cancer survivors on proton pump inhibitors. Journal of Cancer Survivorship 14:2, pages 226-234.
Crossref
Crossref
Mackenzi Pergolotti, Nicolò Matteo Luca Battisti, Lynne Padgett, Alix G. Sleight, Maya Abdallah, Robin Newman, Kathleen Van Dyk, Kelley R. Covington, Grant R. Williams, Frederiek van den Bos, YaoYao Pollock, Elizabeth A. Salerno, Allison Magnuson, Isabella F. Gattás-Vernaglia & Tim A. Ahles. (2020) Embracing the complexity: Older adults with cancer-related cognitive decline—A Young International Society of Geriatric Oncology position paper. Journal of Geriatric Oncology 11:2, pages 237-243.
Crossref
Crossref
Benjamin Ongnok, Nipon Chattipakorn & Siriporn C. Chattipakorn. (2020) Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions. Experimental Neurology 324, pages 113118.
Crossref
Crossref
Mohamed Gamal Kotb, Abd El Rahman Soliman, Rasha Ibrahim Ibrahim, Rasha Magdy Mohamed Said & Mona Mokhtar Wahid El Din. (2019) Chemotherapy-induced cognitive impairment in hematological malignancies. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 55:1.
Crossref
Crossref
Todd S Horowitz, Melissa Treviño, Ingrid M Gooch & Korrina A Duffy. (2019) Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of Meta-Analyses. JNCI: Journal of the National Cancer Institute 111:10, pages 1009-1015.
Crossref
Crossref
Fulvia Di Iulio, Luca Cravello, Jacob Shofany, Stefano Paolucci, Carlo Caltagirone & Giovanni Morone. (2019) Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options. Neurological Sciences 40:9, pages 1759-1774.
Crossref
Crossref
A. Matsos & I.N. Johnston. (2019) Chemotherapy-induced cognitive impairments: A systematic review of the animal literature. Neuroscience & Biobehavioral Reviews 102, pages 382-399.
Crossref
Crossref
R.M. Barrientos, P.J. Brunton, K.M. Lenz, L. Pyter & S.J. Spencer. (2019) Neuroimmunology of the female brain across the lifespan: Plasticity to psychopathology. Brain, Behavior, and Immunity 79, pages 39-55.
Crossref
Crossref
Daniel S.J. Costa & Joanna E. Fardell. (2019) Why Are Objective and Perceived Cognitive Function Weakly Correlated in Patients With Cancer?. Journal of Clinical Oncology 37:14, pages 1154-1158.
Crossref
Crossref
Nira Cedres, Alejandra Machado, Yaiza Molina, Patricia Diaz-Galvan, Juan Andres Hernández-Cabrera, Jose Barroso, Eric Westman & Daniel Ferreira. (2019) Subjective Cognitive Decline Below and Above the Age of 60: A Multivariate Study on Neuroimaging, Cognitive, Clinical, and Demographic Measures. Journal of Alzheimer's Disease 68:1, pages 295-309.
Crossref
Crossref
Leslie Chang, Lauren S. Weiner, Sheri J. Hartman, Steve Horvath, Dilip Jeste, Paul S. Mischel & Deborah M. Kado. (2019) Breast cancer treatment and its effects on aging. Journal of Geriatric Oncology 10:2, pages 346-355.
Crossref
Crossref
Manuela Vasconcelos Castro Sales, Claudia K. Suemoto, Daniel Apolinario, ValeriaT. Serrao, Celi S. Andrade, David M. Conceição, Edson AmaroJr.Jr., Brian Alvarez Ribeiro de Melo & Rachel P. Riechelmann. (2019) Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer. Clinical Colorectal Cancer 18:1, pages 19-27.
Crossref
Crossref
Kathleen Van Dyk, Catherine M. Crespi, Julienne E. Bower, Steven A. Castellon, Laura Petersen & Patricia A. Ganz. (2018) The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment. Cancer 125:5, pages 681-689.
Crossref
Crossref
Janette L. Vardy, Myrle M. Stouten-Kemperman, Gregory Pond, Christopher M. Booth, Sean B. Rourke, Haryana M. Dhillon, Anna Dodd, Adrian Crawley & Ian F. Tannock. (2017) A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer. Brain Imaging and Behavior 13:1, pages 15-26.
Crossref
Crossref
Omid Kardan, Patricia A. Reuter-Lorenz, Scott Peltier, Nathan W. Churchill, Bratislav Misic, Mary K. Askren, Mi Sook Jung, Bernadine Cimprich & Marc G. Berman. (2019) Brain connectivity tracks effects of chemotherapy separately from behavioral measures. NeuroImage: Clinical 21, pages 101654.
Crossref
Crossref
C. Borghgraef & D. Razavi. 2019. Psycho-Oncologie de L'adulte. Psycho-Oncologie de L'adulte
235
245
.
Mariana E. Bradshaw & Jeffrey S. Wefel. 2019. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
427
442
.
Gregg L. Caporaso. 2019. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
147
168
.
Allison Barrie, Steven Plaxe, Robert Krouse & Noreen M. Aziz. 2019. Fundamentals of Cancer Prevention. Fundamentals of Cancer Prevention
723
769
.
Afroz S. Mohammad, Chris E. Adkins, Neal Shah, Rawaa Aljammal, Jessica I. G. Griffith, Rachel M. Tallman, Katherine L. Jarrell & Paul R. Lockman. (2018) Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer. BMC Cancer 18:1.
Crossref
Crossref
Helena Carreira, Rachael Williams, Martin Müller, Rhea Harewood, Susannah Stanway & Krishnan Bhaskaran. (2018) Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review. JNCI: Journal of the National Cancer Institute 110:12, pages 1311-1327.
Crossref
Crossref
Kajal Gokal, Fehmidah Munir, Samreen Ahmed, Kiran Kancherla & Deborah Wallis. (2018) Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial. PLOS ONE 13:11, pages e0206874.
Crossref
Crossref
Inge M Krul, Annemieke W J Opstal-van Winden, Josée M Zijlstra, Yolande Appelman, Sanne B Schagen, Lilian J Meijboom, Erik Serné, Cornelis B Lambalk, Paul Lips, Eline van Dulmen-den Broeder, Michael Hauptmann, Laurien A Daniëls, Berthe M P Aleman & Flora E van Leeuwen. (2018) Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA). BMJ Open 8:9, pages e018120.
Crossref
Crossref
Lori J. Bernstein, Gregory R. Pond, Hui K. Gan, Kattleya Tirona, Kelvin K. Chan, Andrew Hope, John Kim, Eric X. Chen, Lillian L. Siu & Albiruni R. Abdul Razak. (2018) Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort. Head & Neck 40:9, pages 2029-2042.
Crossref
Crossref
Rebecca A. Harrison & Jeffrey S. Wefel. (2018) Neurocognitive Function in Adult Cancer Patients. Neurologic Clinics 36:3, pages 653-674.
Crossref
Crossref
Shireen Marzouk, Gary Naglie, George Tomlinson, Sarah Duff Canning, Henriette Breunis, Narhari Timilshina & Shabbir M.H. Alibhai. (2018) Impact of Androgen Deprivation Therapy on Self-Reported Cognitive Function in Men with Prostate Cancer. Journal of Urology 200:2, pages 327-334.
Crossref
Crossref
Victoria J. Bray, Haryana M. Dhillon & Janette L. Vardy. (2018) Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. Journal of Cancer Survivorship 12:4, pages 537-559.
Crossref
Crossref
Tim A. AhlesJames C. Root. (2018) Cognitive Effects of Cancer and Cancer Treatments. Annual Review of Clinical Psychology 14:1, pages 425-451.
Crossref
Crossref
Sara J. HardyKevin R. KrullJeffrey S. WefelMichelle Janelsins. (2018) Cognitive Changes in Cancer Survivors. American Society of Clinical Oncology Educational Book:38, pages 795-806.
Crossref
Crossref
Catherine Bender, John Merriman, Susan Sereika, Amanda Gentry, Frances Casillo, Theresa Koleck, Margaret Rosenzweig, Adam Brufsky, Priscilla McAuliffe, Yehui Zhu & Yvette Conley. (2018) Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer. Oncology Nursing Forum 45:3, pages 308-326.
Crossref
Crossref
Kyle R Noll, Mariana E Bradshaw, Jennie Rexer & Jeffrey S Wefel. (2018) Neuropsychological Practice in the Oncology Setting. Archives of Clinical Neuropsychology 33:3, pages 344-353.
Crossref
Crossref
Faisal S. Ali, Maryam R. Hussain, Carolina Gutiérrez, Petya Demireva, Leomar Y. Ballester, Jiguang-Jay Zhu, Angel Blanco & Yoshua Esquenazi. (2018) Cognitive disability in adult patients with brain tumors. Cancer Treatment Reviews 65, pages 33-40.
Crossref
Crossref
Mary E. Mihuta, Heather J. Green & David H.K. Shum. (2018) Web-based cognitive rehabilitation for survivors of adult cancer: A randomised controlled trial. Psycho-Oncology 27:4, pages 1172-1179.
Crossref
Crossref
M.E. Mihuta, H.J. Green & D.H.K. Shum. (2018) Efficacy of a web-based cognitive rehabilitation intervention for adult cancer survivors: A pilot study. European Journal of Cancer Care 27:2, pages e12805.
Crossref
Crossref
Emilie Le Rhun, Sophie Taillibert & Marc C. Chamberlain. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
435
469
.
Hamzah Bakouni, Samantha Gontijo Guerra, Veronica Chudzinski, Djamal Berbiche & Helen-Maria Vasiliadis. (2017) One-year prospective study on the presence of chronic diseases and subsequent cognitive decline in older adults. Journal of Public Health 39:4, pages e170-e178.
Crossref
Crossref
David C. Geary. (2017) Evolution of Human Sex-Specific Cognitive Vulnerabilities. The Quarterly Review of Biology 92:4, pages 361-410.
Crossref
Crossref
Lori J. Bernstein, Graham A. McCreath, Zahra Komeylian & Jill B. Rich. (2017) Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis. Neuroscience & Biobehavioral Reviews 83, pages 417-428.
Crossref
Crossref
Jennifer N. Vega, Julie Dumas & Paul A. Newhouse. (2017) Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults. The American Journal of Geriatric Psychiatry 25:12, pages 1415-1426.
Crossref
Crossref
Tracy D. Vannorsdall. (2017) Cognitive Changes Related to Cancer Therapy. Medical Clinics of North America 101:6, pages 1115-1134.
Crossref
Crossref
Christie Yao, Lori J. Bernstein & Jill B. Rich. (2017) Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review. Breast Cancer Research and Treatment 166:1, pages 15-28.
Crossref
Crossref
Martina Lichtenfels, Arethuza da Silva Dornelles, Fernanda dos Santos Petry, Martina Blank, Caroline Brunetto de Farias, Rafael Roesler & Gilberto Schwartsmann. (2017) The anticancer estrogen receptor antagonist tamoxifen impairs consolidation of inhibitory avoidance memory through estrogen receptor alpha. Journal of Neural Transmission 124:11, pages 1331-1339.
Crossref
Crossref
Lin Wu, Dandan Guo, Qi Liu, Fei Gao, Xiaochen Wang, Xueying Song, Fuwu Wang & Ren-Zhi Zhan. (2017) Abnormal Development of Dendrites in Adult-Born Rat Hippocampal Granule Cells Induced by Cyclophosphamide. Frontiers in Cellular Neuroscience 11.
Crossref
Crossref
Pok-Ja Oh. (2017) Predictors of cognitive decline in people with cancer undergoing chemotherapy. European Journal of Oncology Nursing 27, pages 53-59.
Crossref
Crossref
Mariana Ramalho, Filipa Fontes, Luís Ruano, Susana Pereira & Nuno Lunet. (2017) Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study. The Breast 32, pages 173-178.
Crossref
Crossref
Victoria J. BrayHaryana M. DhillonMelanie L. BellMichael KabourakisMallorie H. FieroDesmond YipFrances BoyleMelanie A. PriceJanette L. Vardy. (2017) Evaluation of a Web-Based Cognitive Rehabilitation Program in Cancer Survivors Reporting Cognitive Symptoms After Chemotherapy. Journal of Clinical Oncology 35:2, pages 217-225.
Crossref
Crossref
Jung-woo Chae, Terence Ng, Hui Ling Yeo, Maung Shwe, Yan Xiang Gan, Han Kiat Ho & Alexandre Chan. (2016) Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients. PLOS ONE 11:10, pages e0164204.
Crossref
Crossref
Michelle C. Janelsins, Luke J. Peppone, Charles E. Heckler, Shelli R. Kesler, Lisa K. Sprod, James Atkins, Marianne Melnik, Charles Kamen, Jeffrey Giguere, Michael J. Messino, Supriya G. Mohile & Karen M. Mustian. (2016) YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial. Integrative Cancer Therapies 15:3, pages 263-271.
Crossref
Crossref
Venkadesan Rajendran & Deepa Jeevanantham. (2016) Assessment of physical function in geriatric oncology based on International Classification of Functioning, Disability and Health (ICF) framework. Current Geriatrics Reports 5:3, pages 200-212.
Crossref
Crossref
Diane F. Morean & Leora R. Cherney. (2016) Screening for Cognitive Impairment Associated with Chemotherapy for Breast Cancer. Current Breast Cancer Reports 8:3, pages 151-157.
Crossref
Crossref
Philip E. Lee, Mary C. Tierney, Wei Wu, Kathleen I. Pritchard & Paula A. Rochon. (2016) Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Breast Cancer Research and Treatment 158:3, pages 407-420.
Crossref
Crossref
Kah Poh Loh, Michelle C. Janelsins, Supriya G. Mohile, Holly M. Holmes, Tina Hsu, Sharon K. Inouye, Meghan S. Karuturi, Gretchen G. Kimmick, Stuart M. Lichtman, Allison Magnuson, Mary I. Whitehead, Melisa L. Wong & Tim A. Ahles. (2016) Chemotherapy-related cognitive impairment in older patients with cancer. Journal of Geriatric Oncology 7:4, pages 270-280.
Crossref
Crossref
Joanne Lewis, Chris Chapparo, Lynette Mackenzie & Judy Ranka. (2016) Work after breast cancer: Identification of cognitive difficulties using the Perceive, Recall, Plan, and Perform (PRPP) System of Task Analysis. British Journal of Occupational Therapy 79:5, pages 323-332.
Crossref
Crossref
Anne Van Arsdale, Debra Rosenbaum, Gurpreet Kaur, Priya Pinto, Dennis Yi-Shin Kuo, Ruben Barrera, Gary L. Goldberg & Nicole S. Nevadunsky. (2016) Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies. Gynecologic Oncology 141:2, pages 323-328.
Crossref
Crossref
J. A. Lawrence, L. Griffin, E. P. Balcueva, D. L. Groteluschen, T. A. Samuel, G. J. Lesser, M. J. Naughton, L. D. Case, E. G. Shaw & S. R. Rapp. (2015) A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. Journal of Cancer Survivorship 10:1, pages 176-184.
Crossref
Crossref
Zhi-Gang Jiang, Steven A. Fuller & Hossein A. Ghanbari. (2016)
PAN-811 Blocks Chemotherapy Drug-Induced
In Vitro
Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth
. Oxidative Medicine and Cellular Longevity 2016, pages 1-11.
Crossref
Crossref
Kajal Gokal, Fehmidah Munir, Deborah Wallis, Samreen Ahmed, Ion Boiangiu & Kiran Kancherla. (2015) Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol. BMC Public Health 15:1.
Crossref
Crossref
Natasha D. Buchanan, Sabitha Dasari, Juan L. Rodriguez, Judith Lee Smith, M. Elizabeth Hodgson, Clarice R. Weinberg & Dale P. Sandler. (2015) Post-treatment Neurocognition and Psychosocial Care Among Breast Cancer Survivors. American Journal of Preventive Medicine 49:6, pages S498-S508.
Crossref
Crossref
Wilbert Zwart, Huub Terra, Sabine C. Linn & Sanne B. Schagen. (2015) Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?. Nature Reviews Clinical Oncology 12:10, pages 597-606.
Crossref
Crossref
Rex M. Philpot. (2015) Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits. Neurochemical Research 40:10, pages 2018-2031.
Crossref
Crossref
Emilie Le Rhun, Xavier Delbeuck, Claudia Lefeuvre-Plesse, Andrew Kramar, Emilie Skrobala, Florence Pasquier & Jacques Bonneterre. (2015) A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. Breast Cancer Research and Treatment 152:3, pages 569-580.
Crossref
Crossref
Catherine M. Bender, John D. Merriman, Amanda L. Gentry, Gretchen M. Ahrendt, Sarah L. Berga, Adam M. Brufsky, Frances E. Casillo, Meredith M. Dailey, Kirk I. Erickson, Frances M. Kratofil, Priscilla F. McAuliffe, Margaret Q. Rosenzweig, Christopher M. Ryan & Susan M. Sereika. (2015) Patterns of change in cognitive function with anastrozole therapy. Cancer 121:15, pages 2627-2636.
Crossref
Crossref
Laura L. Boles Ponto, Yusuf Menda, Vincent A. Magnotta, Torricia H. Yamada, Natalie L. Denburg & Susan K. Schultz. (2015)
Frontal hypometabolism in elderly breast cancer survivors determined by [
18
F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study
. International Journal of Geriatric Psychiatry 30:6, pages 587-594.
Crossref
Crossref
Miyuki Ono, James M. Ogilvie, Jennifer S. Wilson, Heather J. Green, Suzanne K. Chambers, Tamara Ownsworth & David H. K. Shum. (2015) A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer. Frontiers in Oncology 5.
Crossref
Crossref
Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll & Sanne B. Schagen. (2015) Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA: A Cancer Journal for Clinicians 65:2, pages 123-138.
Crossref
Crossref
Elodie Martin, Véronique Morel, Dominique Joly, Christine Villatte, Noémie Delage, Claude Dubray, Bruno Pereira & Gisèle Pickering. (2015) Rationale and design of a randomized double-blind clinical trial in breast cancer: Dextromethorphan in chemotherapy-induced peripheral neuropathy. Contemporary Clinical Trials 41, pages 146-151.
Crossref
Crossref
Mark Noble, Margot Mayer-Pröschel, Zaibo Li, Tiefei Dong, Wanchang Cui, Christoph Pröschel, Ibro Ambeskovic, Joerg Dietrich, Ruolan Han, Yin Miranda Yang, Christopher Folts, Jennifer Stripay, Hsing-Yu Chen & Brett M. Stevens. (2015) Redox biology in normal cells and cancer: Restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment. Free Radical Biology and Medicine 79, pages 300-323.
Crossref
Crossref
Stacy A. Eisenberg, Keiko Kurita, Megan Taylor‐Ford, David B. Agus, Mitchell E. Gross & Beth E. Meyerowitz. (2014) Intolerance of uncertainty, cognitive complaints, and cancer‐related distress in prostate cancer survivors. Psycho-Oncology 24:2, pages 228-235.
Crossref
Crossref
Florien W. Boele, Christina M.T. Schilder, Mari-Lou de Roode, Jan Berend Deijen & Sanne B. Schagen. (2015) Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Menopause 22:1, pages 17-25.
Crossref
Crossref
. 2015. Evolution of Vulnerability. Evolution of Vulnerability
295
362
.
David C. Geary. 2015. Evolution of Vulnerability. Evolution of Vulnerability
231
281
.
Julienne E. Bower & Patricia A. Ganz. 2015. Improving Outcomes for Breast Cancer Survivors. Improving Outcomes for Breast Cancer Survivors
53
75
.
Patricia A. GanzLaura PetersenSteven A. CastellonJulienne E. BowerDaniel H.S. SilvermanSteven W. ColeMichael R. IrwinThomas R. Belin. (2014) Cognitive Function After the Initiation of Adjuvant Endocrine Therapy in Early-Stage Breast Cancer: An Observational Cohort Study. Journal of Clinical Oncology 32:31, pages 3559-3567.
Crossref
Crossref
Jin-Shei Lai, Lynne I. Wagner, Paul B. Jacobsen & David Cella. (2014) Self-reported cognitive concerns and abilities: two sides of one coin?. Psycho-Oncology 23:10, pages 1133-1141.
Crossref
Crossref
Jeanne S. MandelblattPaul B. JacobsenTim Ahles. (2014) Cognitive Effects of Cancer Systemic Therapy: Implications for the Care of Older Patients and Survivors. Journal of Clinical Oncology 32:24, pages 2617-2626.
Crossref
Crossref
Victoria L. Champion, Lynne I. Wagner, Patrick O. Monahan, Joanne Daggy, Lisa Smith, Andrea Cohee, Kim W. Ziner, Joan E. Haase, Kathy D. Miller, Kamnesh Pradhan, Frederick W. Unverzagt, David Cella, Bilal Ansari & George W. SledgeJrJr. (2014) Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer 120:15, pages 2237-2246.
Crossref
Crossref
Stefan Zimmermann, Rafal Dziadziuszko & Solange Peters. (2014) Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases. Cancer Treatment Reviews 40:6, pages 716-722.
Crossref
Crossref
Graham J. McDougallJr.Jr., JoAnn S. Oliver & Forrest Scogin. (2014) Memory and Cancer: A Review of the Literature. Archives of Psychiatric Nursing 28:3, pages 180-186.
Crossref
Crossref
Jochen Kaiser, Christoph Bledowski & Jörg Dietrich. (2014) Neural correlates of chemotherapy-related cognitive impairment. Cortex 54, pages 33-50.
Crossref
Crossref
Carolina de Medeiros Rimkus, Celi Santos Andrade, Claudia da Costa Leite, Alexander M. McKinney & Leandro Tavares Lucato. (2014) Toxic Leukoencephalopathies, Including Drug, Medication, Environmental, and Radiation-Induced Encephalopathic Syndromes. Seminars in Ultrasound, CT and MRI 35:2, pages 97-117.
Crossref
Crossref
Kim Edelstein & Lori J. Bernstein. (2014) Cognitive Dysfunction after Chemotherapy For Breast Cancer. Journal of the International Neuropsychological Society 20:4, pages 351-356.
Crossref
Crossref
Lori J. Bernstein, Pamela A. Catton & Ian F. Tannock. (2014) Intra-individual Variability in Women with Breast Cancer. Journal of the International Neuropsychological Society 20:4, pages 380-390.
Crossref
Crossref
Stacy D. Sanford, Jennifer L. Beaumont, Zeeshan Butt, Jerry J. Sweet, David Cella & Lynne I. Wagner. (2014) Prospective Longitudinal Evaluation of a Symptom Cluster in Breast Cancer. Journal of Pain and Symptom Management 47:4, pages 721-730.
Crossref
Crossref
N. B. Kholodova, V. M. Sotnikov, N. Iu. Dobrovol'skaia & Iu. A. Ponkratova. (2014) Aspects of encephalopathy in oncologic patients after chemotherapy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 114:12, pages 84.
Crossref
Crossref
Martine M. Goedendorp, Hans Knoop, Marieke F.M. Gielissen, Constans A.H.H.V.M. Verhagen & Gijs Bleijenberg. (2014) The Effects of Cognitive Behavioral Therapy for Postcancer Fatigue on Perceived Cognitive Disabilities and Neuropsychological Test Performance. Journal of Pain and Symptom Management 47:1, pages 35-44.
Crossref
Crossref
Steven Plaxe, Robert Krouse & Noreen M. Aziz. 2014. Fundamentals of Cancer Prevention. Fundamentals of Cancer Prevention
613
655
.
Jie Li, Wuliji O, Wei Li, Zhi-Gang Jiang & Hossein Ghanbari. (2013) Oxidative Stress and Neurodegenerative Disorders. International Journal of Molecular Sciences 14:12, pages 24438-24475.
Crossref
Crossref
Jeanne S. Mandelblatt, Arti Hurria, Brenna C. McDonald, Andrew J. Saykin, Robert A. Stern, John W. VanMeter, Meghan McGuckin, Tiffani Traina, Neelima Denduluri, Scott Turner, Darlene Howard, Paul B. Jacobsen & Tim Ahles. (2013) Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?. Seminars in Oncology 40:6, pages 709-725.
Crossref
Crossref
K. L. Pomykala, P. A. Ganz, J. E. Bower, L. Kwan, S. A. Castellon, S. Mallam, I. Cheng, R. Ahn, E. C. Breen, M. R. Irwin & D. H. S. Silverman. (2013) The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging and Behavior 7:4, pages 511-523.
Crossref
Crossref
Linda M. Ercoli, Steven A. Castellon, Aimee M. Hunter, Lorna Kwan, Barbara A. Kahn-Mills, Paul A. Cernin, Andrew F. Leuchter & Patricia A. Ganz. (2013) Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging and Behavior 7:4, pages 543-553.
Crossref
Crossref
Shelli R. Kesler, Christa Watson, Della Koovakkattu, Clement Lee, Ruth O’Hara, Misty L. Mahaffey & Jeffrey S. Wefel. (2013) Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging and Behavior 7:4, pages 501-510.
Crossref
Crossref
Catherine M. Bender & Bethany D. Thelen. (2013) Cancer and Cognitive Changes: The Complexity of the Problem. Seminars in Oncology Nursing 29:4, pages 232-237.
Crossref
Crossref
Wendy L. Nelson & Jerry Suls. (2013) New Approaches to Understand Cognitive Changes Associated With Chemotherapy for Non-Central Nervous System Tumors. Journal of Pain and Symptom Management 46:5, pages 707-721.
Crossref
Crossref
Suzanne A Eccles, Eric O Aboagye, Simak Ali, Annie S Anderson, Jo Armes, Fedor Berditchevski, Jeremy P Blaydes, Keith Brennan, Nicola J Brown, Helen E Bryant, Nigel J Bundred, Joy M Burchell, Anna M Campbell, Jason S Carroll, Robert B Clarke, Charlotte E Coles, Gary JR Cook, Angela Cox, Nicola J Curtin, Lodewijk V Dekker, Isabel dos Santos Silva, Stephen W Duffy, Douglas F Easton, Diana M Eccles, Dylan R Edwards, Joanne Edwards, D Gareth Evans, Deborah F Fenlon, James M Flanagan, Claire Foster, William M Gallagher, Montserrat Garcia-Closas, Julia M W Gee, Andy J Gescher, Vicky Goh, Ashley M Groves, Amanda J Harvey, Michelle Harvie, Bryan T Hennessy, Stephen Hiscox, Ingunn Holen, Sacha J Howell, Anthony Howell, Gill Hubbard, Nick Hulbert-Williams, Myra S Hunter, Bharat Jasani, Louise J Jones, Timothy J Key, Cliona C Kirwan, Anthony Kong, Ian H Kunkler, Simon P Langdon, Martin O Leach, David J Mann, John F Marshall, Lesley Ann Martin, Stewart G Martin, Jennifer E Macdougall, David W Miles, William R Miller, Joanna R Morris, Sue M Moss, Paul Mullan, Rachel Natrajan, James PB O’Connor, Rosemary O’Connor, Carlo Palmieri, Paul D P Pharoah, Emad A Rakha, Elizabeth Reed, Simon P Robinson, Erik Sahai, John M Saxton, Peter Schmid, Matthew J Smalley, Valerie Speirs, Robert Stein, John Stingl, Charles H Streuli, Andrew N J Tutt, Galina Velikova, Rosemary A Walker, Christine J Watson, Kaye J Williams, Leonie S Young & Alastair M Thompson. (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Research 15:5.
Crossref
Crossref
K. Milbury, A. Chaoul, K. Biegler, T. Wangyal, A. Spelman, C. A. Meyers, B. Arun, J. L. Palmer, J. Taylor & L. Cohen. (2013) Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial. Psycho-Oncology 22:10, pages 2354-2363.
Crossref
Crossref
Marta Simó, Xavier Rifà-Ros, Antoni Rodriguez-Fornells & Jordi Bruna. (2013) Chemobrain: A systematic review of structural and functional neuroimaging studies. Neuroscience & Biobehavioral Reviews 37:8, pages 1311-1321.
Crossref
Crossref
Shelli Kesler, S.M. Hadi Hosseini, Charles Heckler, Michelle Janelsins, Oxana Palesh, Karen Mustian & Gary Morrow. (2013) Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors. Clinical Breast Cancer 13:4, pages 299-306.
Crossref
Crossref
Lise Paquet, Barbara Collins, Xinni Song, Anne Chinneck, Marc Bedard & Shailendra Verma. (2013) A pilot study of prospective memory functioning in early breast cancer survivors. The Breast 22:4, pages 455-461.
Crossref
Crossref
Marleen J. J. Pullens, Jolanda De Vries, Laurence J. C. Van Warmerdam, Marieke A. Van De Wal & Jan A. Roukema. (2012) Chemotherapy and cognitive complaints in women with breast cancer. Psycho-Oncology 22:8, pages 1783-1789.
Crossref
Crossref
Barbara Collins, Joyce MacKenzie, Giorgio A. Tasca, Carole Scherling & Andra Smith. (2012) Cognitive effects of chemotherapy in breast cancer patients: a dose–response study. Psycho-Oncology 22:7, pages 1517-1527.
Crossref
Crossref
Erin O’Farrell, Joyce MacKenzie & Barbara Collins. (2013) Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”. Current Oncology Reports 15:3, pages 260-269.
Crossref
Crossref
Kristy D. Hodgson, Amanda D. Hutchinson, Carlene J. Wilson & Ted Nettelbeck. (2013) A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treatment Reviews 39:3, pages 297-304.
Crossref
Crossref
Patricia A. Ganz, Lorna Kwan, Steven A. Castellon, Amy Oppenheim, Julienne E. Bower, Daniel H. S. Silverman, Steve W. Cole, Michael R. Irwin, Sonia Ancoli-Israel & Thomas R. Belin. (2013) Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance. JNCI: Journal of the National Cancer Institute 105:11, pages 791-801.
Crossref
Crossref
Debra L. Barton, Kelli Burger, Paul J. Novotny, Tom R. Fitch, Sadhna Kohli, Gamini Soori, Mary Beth Wilwerding, Jeff A. Sloan, Lisa A. Kottschade, Kendrith M. RowlandJr.Jr., Shaker R. Dakhil, Daniel A. Nikcevich & Charles L. Loprinzi. (2012) The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Supportive Care in Cancer 21:4, pages 1185-1192.
Crossref
Crossref
Carole Scherling & Andra Smith. (2013) Opening up the Window into “Chemobrain”: A Neuroimaging Review. Sensors 13:3, pages 3169-3203.
Crossref
Crossref
Johan Le Fel, Aurélie Daireaux, Sandrine Vandenbosshe, Natacha Heutte, Olivier Rigal, Katia Rovira, Florence Joly & Vincent Roy. (2013) Impact des traitements en cancérologie sur les fonctions cognitives : le point de vue des patients, leur attente et leur souhait de participer à des ateliers de rééducation cognitive. Bulletin du Cancer 100:3, pages 223-229.
Crossref
Crossref
H. Taillia. (2013) Qu’en-est-il du chemobrain ?. Revue Neurologique 169:3, pages 216-222.
Crossref
Crossref
Patricia A. Ganz, J.E. Bower, L. Kwan, S.A. Castellon, D.H.S. Silverman, C. Geist, E.C. Breen, M.R. Irwin & S.W. Cole. (2013) Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?. Brain, Behavior, and Immunity 30, pages S99-S108.
Crossref
Crossref
Federica Andreis, Marco Ferri, Maria Mazzocchi, Fausto Meriggi, Anna Rizzi, Luigina Rota, Brunella Di Biasi, Chiara Abeni, Claudio Codignola, Renzo Rozzini & Alberto Zaniboni. (2012) Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study. Supportive Care in Cancer 21:2, pages 583-590.
Crossref
Crossref
Mandy J. Bell, Lauren Terhorst & Catherine M. Bender. (2013) Psychometric Analysis of the Patient Assessment of Own Functioning Inventory in Women With Breast Cancer. Journal of Nursing Measurement 21:2, pages 320-334.
Crossref
Crossref
Susan K. Conroy, Brenna C. McDonald, Dori J. Smith, Lyndsi R. Moser, John D. West, Lisa M. Kamendulis, James E. Klaunig, Victoria L. Champion, Frederick W. Unverzagt & Andrew J. Saykin. (2012) Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Research and Treatment 137:2, pages 493-502.
Crossref
Crossref
Gregg L. Caporaso. 2013. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
89
107
.
Mariana E. Witgert & Jeffrey S. Wefel. 2013. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
443
454
.
S M Hadi Hosseini, Della Koovakkattu & Shelli R Kesler. (2012) Altered small-world properties of gray matter networks in breast cancer. BMC Neurology 12:1.
Crossref
Crossref
Amanda D. Hutchinson, Jessica R. Hosking, Ganessan Kichenadasse, Julie K. Mattiske & Carlene Wilson. (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews 38:7, pages 926-934.
Crossref
Crossref
Tim A. Ahles. (2012) Brain vulnerability to chemotherapy toxicities. Psycho-Oncology 21:11, pages 1141-1148.
Crossref
Crossref
Tim A. AhlesJames C. RootElizabeth L. Ryan. (2012) Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science. Journal of Clinical Oncology 30:30, pages 3675-3686.
Crossref
Crossref
Heather S.L. JimKristin M. PhillipsSari ChaitLeigh Anne FaulMihaela A. PopaYun-Hsiang LeeMallory G. HussinPaul B. JacobsenBrent J. Small. (2012) Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy. Journal of Clinical Oncology 30:29, pages 3578-3587.
Crossref
Crossref
Joseph M. Andreano, James Waisman, Lisa Donley & Larry Cahill. (2011) Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress. Psycho-Oncology 21:10, pages 1091-1098.
Crossref
Crossref
Kelsey L PomykalaDaniel HS Silverman. (2012) Alterations in brain structure and function after chemotherapy for cancer. Future Neurology 7:4, pages 443-452.
Crossref
Crossref
Elham Hedayati, Hassan Alinaghizadeh, Anna Schedin, Håkan Nyman & Maria Albertsson. (2012) Effects of adjuvant treatment on cognitive function in women with early breast cancer. European Journal of Oncology Nursing 16:3, pages 315-322.
Crossref
Crossref
Yin Ting Cheung, Earl Hsien-Jie Tan & Alexandre Chan. (2012) An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Supportive Care in Cancer 20:7, pages 1361-1375.
Crossref
Crossref
Jeffrey S. Wefel & Sanne B. Schagen. (2012) Chemotherapy-Related Cognitive Dysfunction. Current Neurology and Neuroscience Reports 12:3, pages 267-275.
Crossref
Crossref
Stephanie A. Reid-Arndt & Cathy R. Cox. (2012) Stress, Coping and Cognitive Deficits in Women After Surgery for Breast Cancer. Journal of Clinical Psychology in Medical Settings 19:2, pages 127-137.
Crossref
Crossref
Byeongsang Oh, Phyllis N. Butow, Barbara A. Mullan, Stephen J. Clarke, Philip J. Beale, Nick Pavlakis, Myeong Soo Lee, David S. Rosenthal, Linda Larkey & Janette Vardy. (2011) Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Supportive Care in Cancer 20:6, pages 1235-1242.
Crossref
Crossref
Mary Louise Kanaskie. (2012) Chemotherapy-Related Cognitive Change: A Principle-Based Concept Analysis. Oncology Nursing Forum 39:3, pages E241-E248.
Crossref
Crossref
K Ribi, J Aldridge, K-A Phillips, A Thompson, V Harvey, B Thürlimann, F Cardoso, O Pagani, A S Coates, A Goldhirsch, K N Price, R D Gelber & J Bernhard. (2012) Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. British Journal of Cancer 106:10, pages 1618-1625.
Crossref
Crossref
C. M. T. Schilder, C. Seynaeve, S. C. Linn, W. Boogerd, L. V. A. M. Beex, C. M. Gundy, J. W. R. Nortier, C. J. H. van de Velde, F. S. A. M. van Dam & S. B. Schagen. (2011) Self‐reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side‐study. Psycho-Oncology 21:5, pages 479-487.
Crossref
Crossref
Vincent KoppelmansMonique M.B. BretelerWillem BoogerdCaroline SeynaeveChad GundySanne B. Schagen. (2012) Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy. Journal of Clinical Oncology 30:10, pages 1080-1086.
Crossref
Crossref
Michelle C. Janelsins, Karen M. Mustian, Oxana G. Palesh, Supriya G. Mohile, Luke J. Peppone, Lisa K. Sprod, Charles E. Heckler, Joseph A. Roscoe, Alan W. Katz, Jacqueline P. Williams & Gary R. Morrow. (2011) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Supportive Care in Cancer 20:4, pages 831-839.
Crossref
Crossref
J. Howard-Anderson, P. A. Ganz, J. E. Bower & A. L. Stanton. (2012) Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic Review. JNCI Journal of the National Cancer Institute 104:5, pages 386-405.
Crossref
Crossref
Denise D. Correa & Lisa M. Hess. (2012) Cognitive function and quality of life in ovarian cancer. Gynecologic Oncology 124:3, pages 404-409.
Crossref
Crossref
Patricia A. Ganz. (2012) “Doctor, Will the Treatment You Are Recommending Cause Chemobrain?”. Journal of Clinical Oncology 30:3, pages 229-231.
Crossref
Crossref
Summer F. Acevedo. (2012) Why, after Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?. Breast Cancer: Basic and Clinical Research 6, pages BCBCR.S10293.
Crossref
Crossref
Cassia R. Overk, Pei-Yi Lu, Yue-Ting Wang, Jaewoo Choi, James W. Shaw, Gregory R. Thatcher & Elliott J. Mufson. (2012) Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice. Neurobiology of Disease 45:1, pages 479-487.
Crossref
Crossref
Thane Fremouw, Christy L. Fessler, Robert J. Ferguson & Yamil Burguete. (2012) Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin–cyclophosphamide combination treatment. Behavioural Brain Research 226:1, pages 154-162.
Crossref
Crossref
Mei-Ling Chen, Christine Miaskowski, Li-Ni Liu & Shin-Cheh Chen. (2011) Changes in perceived attentional function in women following breast cancer surgery. Breast Cancer Research and Treatment 131:2, pages 599-606.
Crossref
Crossref
Peter Wigmore. 2013. Neurogenesis and Neural Plasticity. Neurogenesis and Neural Plasticity
211
240
.
Lynn M. Breckenridge, Gina L. Bruns, Briana L. Todd & Michael Feuerstein. (2010) Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Psycho-Oncology 21:1, pages 43-53.
Crossref
Crossref
K. Kurita, B. E. Meyerowitz, P. Hall & M. Gatz. (2011) Long-term Cognitive Impairment in Older Adult Twins Discordant for Gynecologic Cancer Treatment. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 66A:12, pages 1343-1349.
Crossref
Crossref
Lea Ann Ouimet, Angela Stewart, Barbara Collins, Dwayne Schindler & Catherine Bielajew. (2011) Investigation of a neuropsychological screen for chemo-fog. Oncology Reviews 5:4, pages 205-213.
Crossref
Crossref
Ellen A. Walker, John J. Foley, Rachel Clark-Vetri & Robert B. Raffa. (2011) Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology 217:4, pages 539-548.
Crossref
Crossref
John D. Merriman, Marylin Dodd, Kathryn Lee, Steven M. Paul, Bruce A. Cooper, Bradley E. Aouizerat, Patrick S. Swift, William Wara, Laura Dunn & Christine Miaskowski. (2011) Differences in Self-reported Attentional Fatigue Between Patients With Breast and Prostate Cancer at the Initiation of Radiation Therapy. Cancer Nursing 34:5, pages 345-353.
Crossref
Crossref
J E Fardell, J Vardy, I N Johnston & G Winocur. (2011) Chemotherapy and Cognitive Impairment: Treatment Options. Clinical Pharmacology & Therapeutics 90:3, pages 366-376.
Crossref
Crossref
Hui K. Gan, Lori J. Bernstein, Jennifer Brown, Jolie Ringash, Mehrdad Vakilha, Lisa Wang, David Goldstein, John Kim, Andrew Hope, Brian O'Sullivan, John Waldron, Albiruni R. Abdul Razak, Eric X. Chen & Lillian L. Siu. (2011) Cognitive Functioning After Radiotherapy or Chemoradiotherapy for Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 81:1, pages 126-134.
Crossref
Crossref
Jeffrey S Wefel, Janette Vardy, Tim Ahles & Sanne B Schagen. (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet Oncology 12:7, pages 703-708.
Crossref
Crossref
Michelle C. Janelsins, Sadhna Kohli, Supriya G. Mohile, Kenneth Usuki, Tim A. Ahles & Gary R. Morrow. (2011) An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status. Seminars in Oncology 38:3, pages 431-438.
Crossref
Crossref
Seongmi Moon, Sun-Hee Kim & Mi-Ja Kim. (2011) Perceived Cognitive Function and Related Factors in Korean Women With Breast Cancer. Asian Nursing Research 5:2, pages 141-150.
Crossref
Crossref
M. Lange, B. Giffard, F. Eustache, N. Morel, S. Noal & F. Joly. (2011) Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littératureImpact of adjuvant chemotherapy on cognitive functions in breast cancer: literature review. Psycho-Oncologie 5:1, pages 3-10.
Crossref
Crossref
Displaying 200 of 300 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list